¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"clinical end point"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end-to-end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¸Â¹°¸², ´Ü´Ü±³ÇÕ
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
  • end
    ³¡, Á¾¸», ¸»´Ü
  • end apparatus
    Á¾¸»ÀåÄ¡
  • end artery
    ³¡µ¿¸Æ
  • end group
    ¸»´Ü±â
  • end organ
    Á¾¸»±â°ü
  • end organ deafness
    Á¾¸»±â°ü³­Ã»
  • end product
    ÃÖÁ¾»ê¹°
  • end-brush
    Ãà»è³¡°¡Áö
  • end-bud
    ²¿¸®½Ï
  • end-diastolic
    È®À帻±â
  • end-diastolic pressure
    È®Àå±â¸»¾Ð·Â
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clinical
    Áø·á-. ÀÓ»ó-
  • objective structured clinical (OSCE) examination
    °´°ü±¸Á¶È­Áø·á½ÃÇè
  • clinical manifestation
    ÀÓ»óÁõ»ó, ÀÓ»ó¼Ò°ß
  • clinical trial
    ÀÓ»ó½ÃÇè
  • end organ
    Á¾¸»±â°ü
  • end product
    ÃÖÁ¾»ê¹°
  • positive end expiratory pressure
    ³¯¼û³¡¾ç¾Ð, È£±â¸»¾ç¾Ð
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • point
    Á¡
  • blind point
    ¸ÍÁ¡
  • critical point
    ÀÓ°èÁ¡
  • near point
    ±ÙÁ¡
  • reference point
    ±âÁØÁ¡
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end to end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¹°¸², ´Ü´Ü±³ÇÕ
  • end-point nystagmus
    ±ØÀ§´«¶³¸², ±ØÀ§¾ÈÁø
  • acromial end
    ºÀ¿ì¸®³¡
  • apical end
    ²ÀÁö³¡
  • end apparatus
    Á¾¸»ÀåÄ¡
  • end artery
    ³¡µ¿¸Æ
  • end to side anastomosis
    ³¡¿·¿¬°á(¼ú), ´ÜÃø¿¬°á(¼ú)
  • Krause¡¯s end bulb
    Å©¶ó¿ìÁ¦³¡¸Á¿ï
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
  • end-organ deafness
    Á¾¸»±â°ü³­Ã»
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡
  • end
    ³¡
  • end-brush
    Ãà»è³¡°¡Áö
  • end-bud
    ²¿¸®½Ï
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • point to point correspondence
    Á¡´ëÁ¡´ëÀÀ(ïÇÓßïÇÓßëë).
  • Clinical data
    ÀÓ»óÀÚ·á
  • Clinical skills
    ÀÓ»ó¼ú±â
  • GCP : good clinical practice
    ÀÓ»ó½ÃÇè °ü¸®±âÁØ.
  • Good Clinical Practice(GCP)
    ÀǾàǰ ÀÓ»ó½ÃÇè °ü¸®±âÁØ
  • SCAG, Sandoz Clinical Assessment-Geriatric
    »êµµ½º ³ëÀÎÀÓ»óÆò°¡(-ôµµ)
  • SCAN, Schedule for Clinical Assessment in Neuropsychaitry
    ½Å°æÁ¤½Å°ú¿¡ ÀÖ¾î ÀÓ»óÆò°¡¸¦ À§ÇÑ ¸ñ·Ï
  • randomized clinical trial
    ¹«ÀÛÀ§ÀÓ»ó½ÇÇè
  • Krause s end bulbs
    Å©¶ó¿ìÁ¦Á¾¸»±¸.
  • Krauses end bulb
    Å©¶ó¿ìÁ¦Á¾¸»±¸
  • MEPP=>miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀü¾Ð
  • MEPP=£¾miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀüÀ§.
  • PEEP(positive end-expiratory pressure)
    È£±â¸» ¾ç¾ÐÈ£Èí
  • acromial end
    ºÀ¿ì¸®³¡
  • advanced glycosylation end products
    ÁøÇ༺´çÈ­Á¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú.
  • end-to-end bite =e. occlusion
    ´Ü´Ü±³ÇÕ.
  • end-to-end implantation
    ´Ü´Ü»ðÀÔ¼ú
  • end-point nystagmus
    ±ØÀ§¾ÈÁø
  • point to point correspondence
    Á¡´ëÁ¡´ëÀÀ(ïÇÓßïÇÓßëë).
  • bacteriology, clinical
    ÀÓ»ó¼¼±ÕÇÐ
  • clinical application
    ÀÓ»óÀûÀÀ¿ë<--Àû¿ë>
  • clinical bacteriology
    ÀÓ»ó¼¼±ÕÇÐ
  • clinical chart
    º´»óÀÏÁö.
  • clinical clerk
    ÀÓ»ó¼­±â(ÊÙË×Ë»).
  • clinical correlation
    ÀÓ»óÀû »ó°ü°ü°è
  • clinical crib
    ÀÓ»ó¿ë À¯¾ÆÄ§´ë(¡­éÄêêä®öÖÓæ).
  • clinical crown
    ÀÓ»óÄ¡¾Æ°ü, ÀÓ»óÄ¡°ü(ìúßÉöÍή).
  • clinical crown
    ÀÓ»óÄ¡¾Æ¸Ó¸®
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Clinical crown
    ÀÓ»óÄ¡¾Æ¸Ó¸®
    [¿¾ ¿ë¾î] ÀÓ»óÄ¡°ü
  • Clinical root
    ÀÓ»óÄ¡¾Æ»Ñ¸®
    [¿¾ ¿ë¾î] ÀÓ»óÄ¡±Ù
  • Sternal end
    º¹À峡
    [¿¾ ¿ë¾î] Èä°ñ´Ü
  • Acromial end
    ºÀ¿ì¸®³¡
    [¿¾ ¿ë¾î] °ßºÀ´Ü
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] ¸»´ÜºÎ
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] Á¾¸»ºÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clinical parasitology
    ÀÓ»ó±â»ýÃæÇÐ
  • apical end
    ÷´ÜºÎ
  • end group spine
    ±ê³¡°¡½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end point
    Á¾¸»Á¡(ðûØÇïÇ)
  • end-point method
    Á¾¸»Á¡¹ý(ðûØÇïÇÛö)
  • end-point mutation
    Á¾¸»Á¡ º¯ÀÌ (ðûØÇïÇܨì¶)
  • advanced glycosylation end product
    ÁøÇà ´çÈ­Á¾»ê¹°(òäú¼ÓØûùðûß§Úª)
  • blunt end ligation
    µÐ´Ü¿¬°á(ÔïÓ®Ö§Ì¿)
  • blunt end
    µÐ´Ü(ÔïÓ®)
  • capped 5'-end
    ĸ °áÇÕ(Ì¿ùê)-5'-Á¾´Ü(ðûÓ®)
  • CCA-end
    CCA Á¾´Ü(ðûÓ®)
  • cohesive end
    Á¡ÂøÁ¾´Ü(ïÄó·ðûÓ®)
  • cohesive end ligation
    Á¡ÂøÁ¾´Ü°áÂû(ïÄó·ðûӮ̿óÎ)
  • dead-end complex
    Á¾¸»º¹ÇÕü(ðûØÇÜÜùêô÷)
  • end absorption
    ³¡ÆÄÀå(÷îíþ) Èí¼ö(ýåâ¥)
  • end carbon chain
    ³¡Åº¼Ò(÷©áÈ) »ç½½
  • end-group analysis
    Á¾´Ü±â ºÐ¼® (ðûÓ®ÐñÝÂà°)
  • end labeling
    Á¾´ÜÇ¥Áö (ðûÓ®øöò½)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clinical application
    ÀÓ»óÀû¿ë
  • end artery
    Á¾µ¿¸Æ
  • hair on end pattern
    °ïµÎ¼±¸ð¹ßÇüÅÂ
  • upper end
    »ó¿¬
  • central point artifact
    Áß½ÉÁ¡Àΰø¹°
  • cut-off point
    °áÁ¤Á¡
  • melting point
    À¶(ÇØ)Á¡, ³ì´ÂÁ¡
  • sylvian point
    ½Çºñ¿ì½ºÁ¡
  • umbilical point
    Á¦Á¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FP false positive; family physician; family planning; family practice; family practitioner; Fanconi pan...
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
EE embryo extract; end-to-end; end expiration; energy expenditure; Enterobacteriaceae enrichment [broth...
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EEA End-to-End Anastomosis
CCP critical control point
CPD Critical point drying
GPA Grade Point Average
HACCP Hazard Analysis Critical Control Point
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • end to end relationship
    Àý´Ü¸é°ú Àý´Ü¸é °ü°è
  • end-to-end
    ³¡°ú ³¡ÀÌ Á¢ÇÑ, öÀúÈ÷, »ô»ôÀÌ
  • end-to-end bite
    ´Ü´Ü ±³ÇÕ
    µ¿ÀǾî=end-to-end occlusion.
  • end-to-end suture
    Àý´Ü´ë Àý´Ü ºÀÇÕ
  • nadir : the lowest point; point of greatest adversity or despair.

    nadisan

    ³ªµð»ê
    ¼ö»êÈ­ ⿬À¸·Î Æ÷È­ÇÑ ÁÖ¼®»ê Ä®·ý ⿬ÀÇ »óǰ¸í.
  • advanced glycosylation end products
    ÁøÇ༺ ´çÈ­ Á¾¸» »ý¼º¹°
  • central end
    Á᫐ ¸»´Ü
  • end apparatus
    Á¾¸» ÀåÄ¡
  • end feel
    Á¾¸»°¨, Á¾¸» °¨°¢
  • end path
    Á¾·Î
  • end-expiration
    È£Èí °áÇ٠ȣ±â ¸»±â
  • end-feel
    Á¾¸»°¨
    ¿ÏÀüÇÑ ´Éµ¿ °³±¸·ÎºÎÅÍ ¿ÏÀüÇÑ ¼öµ¿ °³±¸±îÁö °üÀýÀ» ¼ÕÀ¸·Î Á¶ÀÛÇÏ´Â µ¿¾È ´À²¸Áö´Â ÀúÇ×°¨.
  • end-organ
    Á¾¸» ±â°ü, ¸»´Ü±â, Á¾¸» ½Å°æ ¼Òü
    Áö°¢ ½Å°æÀÇ ÇÇÆ÷µÈ Ä¿´Ù¶õ Á¾¸»ºÎ.
  • free end saddle partial denture
    À¯¸®´Ü ±¹ºÎ ÀÇÄ¡
    ¾Ç±ÃÀÇ ÈĹ濡 ÀÜÁ¸Ä¡°¡ ÆíÃø ¶Ç´Â ¾çÃø¼ºÀ¸·Î ¾øÀ» ¶§ Á¦ÀÛµÈ ±¹¼Ò ÀÇÄ¡ÀÌ´Ù.
  • joint end-feel
    °üÀý Á¾¸»°¨
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
end-to-end bite An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
end-to-end occlusion An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
skin test end-point titration A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy.
(12 Dec 1998)
end point <chemistry> It is the completion point during a titration reaction where there are equal amounts of titrant and whatever is being titrated. It is usually evident by the first perceptible alteration of the colour of an added indicator.
<immunology> It is the most dilute an antibody or antiserum solution can be while still detectably reacting with the antigen.
<statistics> A category of data used to compare the outcome in different arms of a clinical trial. Common endpoints are severe toxicity, disease progression or fall in such surrogate markers as CD4 count, but sometimes death is used as an endpoint.
(08 Mar 2000)
end-point measurement Analytical measurement at the end of a chemical reaction, as opposed to making the measurement while the reaction proceeds.
(05 Mar 2000)
end-point nystagmus A jerky, physiologic nystagmus occurring in a normal individual when attempts are made to fixate a point at the limits of the field of fixation.
Synonym: deviational nystagmus.
(05 Mar 2000)
acromial end of clavicle The flattened lateral end of the clavicle that articulates with the acromion and is anchored to the coracoid process by the conoid and trapezoid ligaments.
Synonym: extremitas acromialis claviculae, acromial end of clavicle.
(05 Mar 2000)
blunt-end Refers to double-stranded DNA in which there are no unpaired bases at the end.
(05 Mar 2000)
blunt-end DNA <molecular biology> A fragment of a DNA molecule in which the ends of both strands are even with each other rather than one strand being longer than the other.
(09 Oct 1997)
blunt-end ligation A lab technique to join together two pieces of blunt-end DNA, such as an insert into a cloning vector, which requires the enzyme ligase because there are no single-stranded overhanging ends for the attachment to form more spontaneously, by itself.
(09 Oct 1997)
by-end Private end or interest; secret purpose; selfish advantage.
Alternative forms: bye-end.
(20 Mar 1998)
capped 5'-end A methylated (has a -CH3 attached) guanosine nucleotide attached to the 5'-end (the beginning) of an eukaryotic mRNA, thought to give the mRNA stability.
(09 Oct 1997)
glycosylation end products, advanced Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus.
(12 Dec 1998)
root end cyst An inflammatory odontogenic cyst derived histogenetically from Malassez' epithelial rests surrounding the root apex of a nonvital tooth.
Synonym: periapical cyst, radicular cyst, root end cyst.
(05 Mar 2000)
root end granuloma Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end point
    Á¾·áÁ¡;Á¾Á¡;(È­)(ÀûÁ¤ÀÇ)Á¾Á¡;=ENDPOINT
  • clinical
    ÀÓ»óÀÇ
  • clinical
    ÀÓ»óÀÇ;º´»óÀÇ;º´½Ç¿ëÀÇ;(ÆÇ´Ü.¹¦»çµîÀÌ ±Øµµ·Î)°´°üÀûÀÎ;ºÐ¼®ÀûÀÎ;³ÃÁ¤ÇÑ;º´»ó(ÀÓÁ¾)ÀÇ (¼¼·Ê);~ly ÀÓ»óÀûÀ¸·Î
  • clinical death
    ÀÓ»ó»ç(±â±â¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°í ÀÓ»óÀû °üÂû·Î ÆÇ´ÜÇÑ Á×À½)
  • clinical ecologist
    ÀÓ»ó »ýÅÂÇÐÀÚ
  • clinical ecology
    ÀÓ»ó »ýÅÂÇÐ
  • clinical pathology
    ÀÓ»ó º´¸®ÇÐ
  • clinical pharmacology
    ÀÓ»ó ¾àÇÐ
  • clinical psychology
    ÀÓ»ó ½É¸®ÇÐ
  • by-end
    À̱âÀûÀÎ µ¿±â
  • end
    ³¡,¸ñÀû,°á¸»
  • to the end
    ³¡±îÁö
  • END
    European Nuclear Disarmament
  • East End
    ·±´ø µ¿Á· ³¡(ÀÌÀüÀÇ ºó¹Î°¡)
  • Land's End
    ¿µ±¹ Cornwall ÁÖ ¼­´ÜÀÇ ²É
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á